Literature DB >> 15637668

Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.

Lester J Layfield1, Harvey Cramer.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology characterized by ongoing inflammation, destruction, and fibrosis of intrahepatic and extrahepatic bile ducts. Irregular narrowing and dilation of the biliary duct system produces the characteristic beaded pattern seen on cholangiogram. Malignant degeneration resulting in cholangiocarcinoma is a well-recognized sequela of PSC. Bile duct brushing cytology is the primary screening technique for cholangiocarcinoma. It is associated with a relatively low sensitivity but high specificity. Few false positive bile duct brushings have been reported in the literature, with the majority of these having occurred in a background of PSC. We report two patients with PSC in whom bile duct brush cytologies were falsely positive for carcinoma. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15637668     DOI: 10.1002/dc.20192

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  False negative and false positive rates in common bile duct brushing cytology, a single center experience.

Authors:  Bita Geramizadeh; Maryam Moughali; Atefeh Shahim-Aein; Soghra Memari; Ziba Ghetmiri; Alireza Taghavi; Kamran Bagheri Lankarani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

2.  Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines.

Authors:  Martha B Pitman; Barbara A Centeno; Syed Z Ali; Muriel Genevay; Ed Stelow; Mari Mino-Kenudson; Carlos Fernandez-Del Castillo; C Max Schmidt; William R Brugge; Lester J Layfield
Journal:  Cytojournal       Date:  2014-06-02       Impact factor: 2.091

3.  Difficulty Achieving a Preoperative Diagnosis of IgG4-Related Sclerosing Cholangitis.

Authors:  Kazuhiro Suzumura; Etsuro Hatano; Masaharu Tada; Hideaki Sueoka; Hiroshi Nishida; Kenjiro Iida; Seikan Hai; Hayato Miyamoto; Tatsuya Andoh; Takahiro Ueki; Kentaro Nonaka; Keiji Nakasho; Jiro Fujimoto
Journal:  Case Rep Gastroenterol       Date:  2018-08-21

4.  Refined pancreatobiliary UroVysion criteria and an approach for further optimization.

Authors:  Daniel Mettman; Azhar Saeed; Janna Shold; Raquele Laury; Andrew Ly; Irfan Khan; Shivani Golem; Mojtaba Olyaee; Maura O'Neil
Journal:  Cancer Med       Date:  2021-08-10       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.